About IVI
We are an independent nonprofit research organization that:
Patient-Centered
We champion a focus on patient-centered outcomes and preferences as drivers of change
Equity
We provide equity in all aspects of healthcare, so that all patients have a fair and just opportunity to achieve optimal health
Transparency
We advocate transparent, open-source model development to improve dialogue and build trust among users, decision-makers, and patient communities
Our Mission
To advance the science, practice, and use of patient-centered Health Technology Assessment to support decisions that make healthcare more meaningful and equitable.
Our Vision
A learning healthcare system supported by patient-centered Health Technology Assessment and focused on high-quality, efficient, innovative, and equitable care for all people and communities.
Moving Forward
IVI is leading the conversation around new methods for advancing the science of Health Technology Assessment.
This includes our work centering the patient and incorporating equity into the entire HTA process. Looking to the future, we want to demonstrate how methods are used in the real world through use cases and expand into other areas such as rare disease, digital health, and diagnostics. IVI will also continue shaping the policy environment, influencing how the government examines value.
The success of our work is based on collaboration. We will continue diversifying our membership and expanding our partnerships, working with other leading organizations that share our mission and purpose.
IVI’s Principles for Health Technology Assessment in the U.S. »
OUR HISTORY
- IVI is founded by Precision Health Economics, as an incubator for novel methods and development for HTA.
- IVI releases its first disease-specific HTA model, for rheumatoid arthritis, as part of the Open-Source Value Project (OSVP).
- IVI names Momentum Health Strategies as its first leadership team.
- IVI transitions to an independent non-profit membership organization, governed by a Board of Directors.
- Release of IVI’s second OSVP disease-specific HTA model, addressing non-small cell lung cancer (NSCLC).
- IVI is selected by the Patient-Centered Outcomes Research Institute (PCORI) for a Eugene Washington PCORI Engagement Award.
- IVI announces its first Chief Science Officer.
- IVI hosts its inaugural Annual Methods Summit, focusing on accelerating the alignment of HTA methods with real-world decision needs.
- Launch of IVI Patient Advisory Council, an advisory body designed to ensure the patient always remains at the forefront of our research.
- Development begins on our third OSVP disease-specific model, which focuses on major depressive disorder (MDD).
- IVI releases its Nine Principles for HTA in the U.S.
Experts driving the future of patient-centered metrics in HTA for better patient outcomes.
Join us at the forefront of health equity and patient-focused healthcare.
A research-based plan for putting the principle of patient-centricity into practice.
IVI’s work spans the breadth and depth of the Health Technology Assessment ecosystem.